Free Trial

Nutex Health (NASDAQ:NUTX) Stock Price Up 8.1% - What's Next?

Nutex Health logo with Medical background

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) shot up 8.1% during trading on Monday . The company traded as high as $130.00 and last traded at $128.02. 73,546 shares changed hands during mid-day trading, a decline of 15% from the average session volume of 86,986 shares. The stock had previously closed at $118.37.

Wall Street Analyst Weigh In

A number of research firms have recently commented on NUTX. Maxim Group raised their price objective on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Finally, Benchmark lifted their price target on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research note on Thursday, May 15th.

Get Our Latest Stock Analysis on NUTX

Nutex Health Trading Up 1.7%

The company has a market capitalization of $653.91 million, a PE ratio of 9.89 and a beta of -0.04. The firm's 50 day moving average is $135.41 and its 200 day moving average is $88.97. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $2.71. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%. The company had revenue of $211.79 million for the quarter, compared to analysts' expectations of $81.09 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NUTX. Goldman Sachs Group Inc. boosted its position in shares of Nutex Health by 17.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company's stock valued at $852,000 after acquiring an additional 2,748 shares during the last quarter. Jane Street Group LLC purchased a new position in Nutex Health in the first quarter valued at about $522,000. OMERS ADMINISTRATION Corp lifted its position in Nutex Health by 28.8% during the first quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock valued at $442,000 after purchasing an additional 2,100 shares during the period. American Century Companies Inc. lifted its position in shares of Nutex Health by 73.0% during the 1st quarter. American Century Companies Inc. now owns 74,359 shares of the company's stock valued at $3,497,000 after buying an additional 31,366 shares in the last quarter. Finally, Informed Momentum Co LLC purchased a new position in Nutex Health in the 1st quarter valued at about $868,000. 5.32% of the stock is currently owned by institutional investors.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

See Also

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines